Absolute numbers and percentages (in parenthesis) of specimens showing normal/reactive lesions, benign tumours, low-grade premalignant, high-grade premalignant and malignant tumours in each location
| Location | Normal/reactive | Benign tumours | Low-grade premalignant lesions | High-grade premalignant lesions | Malignant tumours |
|---|---|---|---|---|---|
| Vulva | 7 (36.8) | 6 (31.6) | 0 (0) | 5 (26.3) | 1 (5.3) |
| Vagina | 8 (66.7) | 0 (0) | 0 (0) | 0 (0) | 4 (33.3) |
| Uterine cervix | 64 (51.2) | 3 (2.4) | 16 (12.8) | 37 (29.6) | 5 (4.0) |
| Endocervix | 30 (65.2) | 9 (19.6) | 2 (4.3) | 3 (6.6) | 2 (4.3) |
| Endometrium | 29 (48.3) | 28 (46.7) | 0 (0) | 1 (1.7) | 2 (3.3) |
| Uterus | 13 (18.8) | 46 (66.7) | 0 (0) | 2 (2.9) | 8 (11.6) |
| Fallopian tube | 7 (58.3) | 5 (41.7) | 0 (0) | 0 (0) | 0 (0) |
| Ovary | 8 (22.2) | 24 (66.7) | 0 (0) | 0 (0) | 4 (11.1) |
| Lymph nodes | 41 (93.2) | 0 (0) | 0 (0) | 0 (0) | 3 (6.8) |
| Peritoneum | 6 (42.9) | 0 (0) | 0 (0) | 0 (0) | 8 (57.1) |
| Other * | 5 (33.3) | 9 (60.0) | 0 (0) | 0 (0) | 1 (6.7) |
*Includes biopsies of the abdominal wall (1), large bowel (9), urinary bladder (4) and ureter (1).